DK1077687T3 - Multipartikulær farmaceutisk form med programmeret og pulserende frigørelse og fremstillingsmetode deraf - Google Patents

Multipartikulær farmaceutisk form med programmeret og pulserende frigørelse og fremstillingsmetode deraf

Info

Publication number
DK1077687T3
DK1077687T3 DK99920897T DK99920897T DK1077687T3 DK 1077687 T3 DK1077687 T3 DK 1077687T3 DK 99920897 T DK99920897 T DK 99920897T DK 99920897 T DK99920897 T DK 99920897T DK 1077687 T3 DK1077687 T3 DK 1077687T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical form
active principle
polymer
hours
multiparticular
Prior art date
Application number
DK99920897T
Other languages
Danish (da)
English (en)
Inventor
Edouard Gendrot
Gerard Cousin
Francoise Ragot
Marie-Christine Clee-Bouvet
Original Assignee
Prographarm Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prographarm Lab filed Critical Prographarm Lab
Application granted granted Critical
Publication of DK1077687T3 publication Critical patent/DK1077687T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK99920897T 1998-05-20 1999-05-20 Multipartikulær farmaceutisk form med programmeret og pulserende frigørelse og fremstillingsmetode deraf DK1077687T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9806384A FR2778848B1 (fr) 1998-05-20 1998-05-20 Forme pharmaceutique multiparticulaire a liberation programmee et pulsee et son procede de preparation
PCT/FR1999/001201 WO1999059557A1 (fr) 1998-05-20 1999-05-20 Forme pharmaceutique multiparticulaire a liberation programmee et pulsee et son procede de preparation

Publications (1)

Publication Number Publication Date
DK1077687T3 true DK1077687T3 (da) 2002-06-17

Family

ID=9526556

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99920897T DK1077687T3 (da) 1998-05-20 1999-05-20 Multipartikulær farmaceutisk form med programmeret og pulserende frigørelse og fremstillingsmetode deraf

Country Status (24)

Country Link
EP (1) EP1077687B1 (enExample)
JP (1) JP2002515423A (enExample)
KR (1) KR100583065B1 (enExample)
CN (1) CN1186014C (enExample)
AT (1) ATE214598T1 (enExample)
AU (1) AU758299B2 (enExample)
BG (1) BG64764B1 (enExample)
BR (1) BR9910606A (enExample)
CA (1) CA2333188C (enExample)
DE (1) DE69901062T2 (enExample)
DK (1) DK1077687T3 (enExample)
ES (1) ES2173739T3 (enExample)
FR (1) FR2778848B1 (enExample)
GE (1) GEP20022750B (enExample)
HU (1) HU224193B1 (enExample)
IL (1) IL139774A (enExample)
MX (1) MXPA00011364A (enExample)
NO (1) NO330501B1 (enExample)
NZ (1) NZ508392A (enExample)
PL (1) PL192950B1 (enExample)
PT (1) PT1077687E (enExample)
TR (1) TR200100107T2 (enExample)
WO (1) WO1999059557A1 (enExample)
ZA (1) ZA200006768B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
US8802139B2 (en) 2003-06-26 2014-08-12 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
EP1802285B1 (en) 2004-10-21 2013-02-27 Aptalis Pharmatech, Inc. Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
AU2013273835B2 (en) * 2005-05-02 2016-07-07 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
WO2008136016A1 (en) * 2007-05-08 2008-11-13 Medreich Limited A stable controlled release oral solid dosage form composition and a process thereof
JP5309262B2 (ja) 2009-12-02 2013-10-09 アプタリス ファーマ リミテッド フェキソフェナジン・マイクロカプセル及びそれを含む組成物
FR2999432B1 (fr) 2012-12-17 2014-12-12 Ethypharm Sa Comprimes orodispersibles obtenus par compression moulage

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2558396B2 (ja) * 1990-06-28 1996-11-27 田辺製薬株式会社 放出制御型製剤
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
FR2754710B1 (fr) * 1996-10-22 1998-12-31 Prographarm Lab Procede de preparation d'une forme pharmaceutique multiparticulaire a liberation controlee plurisequentielle

Also Published As

Publication number Publication date
ES2173739T3 (es) 2002-10-16
CA2333188C (fr) 2010-07-06
AU758299B2 (en) 2003-03-20
DE69901062D1 (de) 2002-04-25
EP1077687B1 (fr) 2002-03-20
FR2778848B1 (fr) 2001-11-23
BG104963A (en) 2001-07-31
BR9910606A (pt) 2001-10-02
ATE214598T1 (de) 2002-04-15
DE69901062T2 (de) 2002-10-31
WO1999059557A1 (fr) 1999-11-25
PL192950B1 (pl) 2006-12-29
CN1186014C (zh) 2005-01-26
EP1077687A1 (fr) 2001-02-28
PT1077687E (pt) 2002-09-30
IL139774A (en) 2005-09-25
NO20005838D0 (no) 2000-11-17
HUP0102027A3 (en) 2002-12-28
GEP20022750B (en) 2002-08-26
NO330501B1 (no) 2011-05-02
CA2333188A1 (fr) 1999-11-25
BG64764B1 (bg) 2006-03-31
FR2778848A1 (fr) 1999-11-26
AU3830299A (en) 1999-12-06
TR200100107T2 (tr) 2001-06-21
PL344314A1 (en) 2001-10-22
MXPA00011364A (es) 2008-09-09
NZ508392A (en) 2002-09-27
NO20005838L (no) 2001-01-10
KR20010052370A (ko) 2001-06-25
KR100583065B1 (ko) 2006-06-08
CN1305371A (zh) 2001-07-25
IL139774A0 (en) 2002-02-10
HK1033271A1 (en) 2001-08-24
HU224193B1 (hu) 2005-06-28
JP2002515423A (ja) 2002-05-28
HUP0102027A2 (hu) 2002-03-28
ZA200006768B (en) 2001-11-20

Similar Documents

Publication Publication Date Title
DK1077687T3 (da) Multipartikulær farmaceutisk form med programmeret og pulserende frigørelse og fremstillingsmetode deraf
NO870558L (no) Fremgangsmaate for fremstilling av et langsomt frigivende farmasoeytisk preparat.
AU2001239658A1 (en) Method for producing a controlled-release preparation
KR950702409A (ko) 방출 조절 모르핀 제제(controlled release morphine preparation)
SG164281A1 (en) Controlled release preparation
HUP9903334A2 (hu) Eljárás morfológiailag egységes mikrokapszulák előállítására, valamint az ezzel az eljárással előállított mikrokapszulák
NO985699L (no) Enterisk belegg omfattende alginsyre, for et oralt preparat
WO2003077842A3 (en) Palatable oral suspension and method
IS5577A (is) Omeprazól örkorn vernduð gegn magasýrum, framleiðsluferli og lyfjasamsetningar
WO2004091538A3 (en) Homogeneous, thermoreversible alginate films and soft capsules made therefrom
DE60036874D1 (de) Pellet formulierung mit gesteuerter freisetzung
DK1663217T3 (da) Faste dispersioner indeholdende tacrolimus
NO20001042D0 (no) Oftalmiske preparater med forsinket frigivelse inneholdende vannoppløselige medikamenter
DE50000639D1 (de) Verfahren zur stabilisierung von polyvinylpyrrolidon-zubereitungen
KR880701543A (ko) 동물의 장구간에 생물학적 활성물질을 방출하는데 유용한 미세과립형 제제
EP0616802A4 (en) Oral preparation for release in lower digestive tracts.
CY1108863T1 (el) Φαρμακευτικο σκευασμα εκτεταμενης απελευθερωσης ανεξαρτητης απο το ρη
AU574220B2 (en) Sustained release drug in ter polymer coat (pvc and pvacand pvom)
WO2004066984A3 (en) Improved taste masking pharmaceutical composition and process for its preparation
DK1417960T3 (da) Mikropellets med vedvarende frisætning og fremgangsmåde til fremstilling heraf
ATE226428T1 (de) Verfahren zur herstellung von pharmazeutischen zusammensetzungen
WO2001051031A3 (en) Enteric coated pharmaceutical formulation
CA2617351A1 (en) Diltiazem controlled release formulation and method of manufacture
TH51671A3 (th) องค์ประกอบทางเภสัชกรรมที่เคลือบเอนเทอริค และวิธีการผลิต
KR870002837A (ko) 지속적으로 방출되게 코오팅된 정제와 그 코오팅된 정제의 제조방법